Life sciences

Our Global Life Sciences sector can help you navigate forward and achieve sustainable success in the new health-outcomes-driven ecosystem.

Aging populations and chronic disease are putting pressure on health resources around the world just as scientific progress, augmented intelligence and digital data are transforming the traditional health care models. This is causing a power shift with new entrants (often not driven by profit) disrupting the incumbents.

Staying competitive and providing the personalized experience that patients demand require life sciences organizations to find new ways of working. Partnering with others to share data, medicine and resources while anticipating trends and regulatory changes will help ensure sustainability in the increasingly evidence-based, outcomes-focused sector.

We help companies across the biotechnology, pharmaceutical and medical technology fields harness this disruption by forming the right alliances, better allocating resources and building trust with customers.

Our latest thinking

Pulse of the MedTech Industry Report

EY MedTech report on dealmaking, financing and state of the industry, with insights on growth and commercial strategies, AI, consumer and more.

John Babitt + 1

EY Biotech Beyond Borders Report 2025

Biotech companies and life sciences leaders are managing uncertainty and preparing to bounce back across the biotechnology landscape. Find out how.

How CDMOs are leading innovation for pharmaceutical partners

Discover how CDMO M&A trends show CDMOs are becoming emerging technology leaders for pharmaceutical partners.

How AI can support decision-making in drug development portfolios

For the pharmaceutical industry, AI can be a powerful tool to drive better-informed asset portfolio decisions.

Learn more (via ey.com US)

A female scientist in a lab

Close up of hand touching smartwatch with health app

Optimizing health outcomes for all

Discover key insights that highlight strategic priorities and investments to enhance care across sectors, along with the evolution of organizational capabilities, based on a survey of 500 industry leaders.

Read the report (via ey.com US)

Pharma promotional content management services

The EY Promotional Content Management Services team can provide you with support that will transform your processes and improve your results. Learn more.
Read more
EY Smart Reviewer

The EY Smart Reviewer can help your business accelerate and optimize the review and approval process for marketing and promotional materials. Find out how.
Read more
Biopharma launch services

Our Biopharma Launch Edge team can help your business achieve successful launches. Find out how.
Read more
EY Health Outcomes Platform

The EY Health Outcomes Platform aligns all stakeholders by providing a practical solution to operate value-based contracts at scale. Find out how.
Read more
Field-force behavioral benchmarking services

Our Field-force Behavioral Benchmarking team can help your business achieve improved commercial performance. Find out how.
Read more
Health and Wellness Strategy Consulting

Our Healthcare Strategy Consulting teams help organizations develop digital, transaction and value strategies to build resilience and drive future growth
Read more

Case studies

How Bayer is unearthing agronomy's future with generative AI

Read this case study to learn how Bayer Crop Science is using large language models to plant the seeds of the future.

The team

Linda Hill

EY Global and Americas Consumer and Health Leader

Strategic leader focused on innovation. Collaborative team builder. Champion for audit quality. Client-centric problem solver. Avid reader. Ambitious hiker. Occasional middle school sports coach.

St. Louis, MO, United States

Daniel Mathews

EY Global Life Sciences Leader; EY EMEIA Life Sciences Market Lead

Passionate about driving health outcomes. Focused on making pharmaceutical innovations affordable and easily accessible to everyone.

London, United Kingdom

On the agenda (0)

Skip

west east

EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients.